Elevance Health EBITDA 2012-2025 | ELV
Elevance Health annual and quarterly EBITDA history from 2012 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Elevance Health EBITDA for the quarter ending December 31, 2025 was $987M, a 26.56% decline year-over-year.
- Elevance Health EBITDA for the twelve months ending December 31, 2025 was $9.658B, a 7.86% decline year-over-year.
- Elevance Health 2025 annual EBITDA was $9.658B, a 7.86% decline from 2024.
- Elevance Health 2024 annual EBITDA was $10.482B, a 0.08% decline from 2023.
- Elevance Health 2023 annual EBITDA was $10.49B, a 3.59% increase from 2022.
|
Elevance Health Annual EBITDA (Millions of US $) |
|
|---|---|
| 2025 | $9,658 |
| 2024 | $10,482 |
| 2023 | $10,490 |
| 2022 | $10,126 |
| 2021 | $10,116 |
| 2020 | $8,212 |
| 2019 | $7,866 |
| 2018 | $6,964 |
| 2017 | $5,876 |
| 2016 | $6,190 |
| 2015 | $6,183 |
| 2014 | $5,901 |
| 2013 | $5,497 |
| 2012 | $5,111 |
| 2011 | $5,025 |
|
Elevance Health Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-12-31 | $987 |
| 2025-09-30 | $2,144 |
| 2025-06-30 | $3,013 |
| 2025-03-31 | $3,514 |
| 2024-12-31 | $1,344 |
| 2024-09-30 | $2,002 |
| 2024-06-30 | $3,601 |
| 2024-03-31 | $3,535 |
| 2023-12-31 | $1,684 |
| 2023-09-30 | $2,339 |
| 2023-06-30 | $3,135 |
| 2023-03-31 | $3,332 |
| 2022-12-31 | $1,747 |
| 2022-09-30 | $2,791 |
| 2022-06-30 | $2,723 |
| 2022-03-31 | $2,865 |
| 2021-12-31 | $2,046 |
| 2021-09-30 | $2,548 |
| 2021-06-30 | $2,872 |
| 2021-03-31 | $2,650 |
| 2020-12-31 | $1,094 |
| 2020-09-30 | $925 |
| 2020-06-30 | $3,639 |
| 2020-03-31 | $2,554 |
| 2019-12-31 | $1,537 |
| 2019-09-30 | $1,975 |
| 2019-06-30 | $1,934 |
| 2019-03-31 | $2,420 |
| 2018-12-31 | $1,013 |
| 2018-09-30 | $1,717 |
| 2018-06-30 | $1,981 |
| 2018-03-31 | $2,253 |
| 2017-12-31 | $798 |
| 2017-09-30 | $1,493 |
| 2017-06-30 | $1,614 |
| 2017-03-31 | $1,971 |
| 2016-12-31 | $1,068 |
| 2016-09-30 | $1,538 |
| 2016-06-30 | $1,860 |
| 2016-03-31 | $1,724 |
| 2015-12-31 | $778 |
| 2015-09-30 | $1,263 |
| 2015-06-30 | $2,201 |
| 2015-03-31 | $1,941 |
| 2014-12-31 | $1,249 |
| 2014-09-30 | $1,525 |
| 2014-06-30 | $1,630 |
| 2014-03-31 | $1,496 |
| 2013-12-31 | $853 |
| 2013-09-30 | $1,408 |
| 2013-06-30 | $1,588 |
| 2013-03-31 | $1,648 |
| 2012-12-31 | $819 |
| 2012-09-30 | $1,346 |
| 2012-06-30 | $1,348 |
| 2012-03-31 | $1,598 |
| 2011-12-31 | $771 |
| 2011-09-30 | $1,305 |
| 2011-06-30 | $1,266 |
| 2011-03-31 | $1,684 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $72.281B | $199.125B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $153.038B | 27.78 |
| HCA Healthcare (HCA) | United States | $113.536B | 17.61 |
| CVS Health (CVS) | United States | $96.185B | 11.06 |
| Cencora (COR) | United States | $70.472B | 22.23 |
| Natera (NTRA) | United States | $29.128B | 0.00 |
| Labcorp Holdings (LH) | United States | $22.715B | 17.32 |
| DiDi Global (DIDIY) | China | $21.744B | 20.09 |
| Viatris (VTRS) | United States | $17.922B | 6.68 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.758B | 0.00 |
| Medpace Holdings (MEDP) | United States | $14.939B | 34.66 |
| Solventum (SOLV) | United States | $13.541B | 13.14 |
| BioMerieux (BMXMF) | France | $13.324B | 0.00 |
| ICON (ICLR) | Ireland | $12.483B | 12.39 |
| CochLear (CHEOY) | Australia | $11.763B | 0.00 |
| Revvity (RVTY) | United States | $11.657B | 20.28 |
| Charles River Laboratories (CRL) | United States | $9.139B | 17.60 |
| Sonic Healthcare (SKHHY) | Australia | $7.779B | 0.00 |
| Avantor (AVTR) | United States | $7.657B | 11.70 |
| BrightSpring Health Services (BTSG) | United States | $7.171B | 42.75 |
| HealthEquity (HQY) | United States | $6.773B | 25.33 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.295B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $5.991B | 39.33 |
| PACS (PACS) | United States | $5.983B | 36.38 |
| Sotera Health (SHC) | United States | $4.946B | 23.85 |
| Alignment Healthcare (ALHC) | United States | $4.154B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.532B | 20.61 |
| Concentras Parent (CON) | United States | $2.966B | 18.51 |
| GeneDx Holdings (WGS) | United States | $2.637B | 46.31 |
| Organon (OGN) | United States | $2.056B | 2.17 |
| Establishment Labs Holdings (ESTA) | United States | $2.020B | 0.00 |
| Progyny (PGNY) | United States | $1.866B | 36.69 |
| Pediatrix Medical (MD) | United States | $1.794B | 10.71 |
| Surgery Partners (SGRY) | United States | $1.744B | 22.47 |
| Ardent Health (ARDT) | United States | $1.290B | 4.21 |
| InnovAge Holding (INNV) | United States | $1.185B | 174.60 |
| CareDx (CDNA) | United States | $1.038B | 16.97 |
| Teladoc Health (TDOC) | United States | $0.884B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.750B | 12.28 |
| Nutex Health (NUTX) | United States | $0.740B | 5.66 |
| Omada Health (OMDA) | United States | $0.660B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.651B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.624B | 0.00 |
| Embecta (EMBC) | United States | $0.610B | 3.40 |
| Enhabit (EHAB) | United States | $0.561B | 25.20 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.487B | 8.96 |
| CryoPort (CYRX) | United States | $0.431B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.404B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| Auna S.A (AUNA) | Luxembourg | $0.355B | 5.71 |
| So-Young (SY) | China | $0.344B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.268B | 0.00 |
| Oncology Institute (TOI) | United States | $0.264B | 0.00 |
| Agilon Health (AGL) | United States | $0.255B | 0.00 |
| Beauty Health (SKIN) | United States | $0.154B | 0.00 |
| LifeMD (LFMD) | United States | $0.154B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.118B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.103B | 0.00 |
| Biodesix (BDSX) | United States | $0.079B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.072B | 0.00 |
| DocGo (DCGO) | United States | $0.071B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.041B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.041B | 0.00 |
| Pomdoctor - (POM) | China | $0.024B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.019B | 5.97 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.012B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |